Uncategorized
What’s Going On With Alterity Therapeutics Shares Thursday?
Alterity Therapeutics shares are moving higher on Thursday after the company reported positive topline results from its Phase 2 clinical trial of ATH434 in early-stage multiple system atrophy. read more
Altria Q4 Earnings Exceed Expectations, Announces $1 Billion Buyback
Altria’s Q4 earnings matched expectations, with a $1 billion share buyback authorized and strong sales growth, while projecting modest 2025 EPS growth of 2-5%. read more
Thermo Fisher Q4 Earnings Beat Estimates, Margin Expands
Thermo Fisher Scientific (TMO) reports Q4 earnings of $6.10 per share, exceeding expectations. Operating income and revenue growth also increased. read more
Levi Strauss Sees Gloomy FY25 Despite Solid Q4, Stock Slides
Levi Strauss shares are down in premarket trading after the company issued a weaker FY25 outlook, projecting revenue declines of 1% to 2%. Levi reported strong Q4 results. read more